Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2441783
Max Phase: Preclinical
Molecular Formula: C54H88N2O17
Molecular Weight: 1037.29
Molecule Type: Unknown
Associated Items:
ID: ALA2441783
Max Phase: Preclinical
Molecular Formula: C54H88N2O17
Molecular Weight: 1037.29
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O[C@@H]3O[C@H](C)[C@@H](OCc4ccccc4)[C@H](N(C)C)[C@H]3O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2OC(=O)O[C@@]21C
Standard InChI: InChI=1S/C54H88N2O17/c1-18-37-54(11)46(72-51(61)73-54)30(4)40(57)28(2)25-52(9,62-16)45(70-49-41(58)36(55(12)13)24-29(3)65-49)31(5)43(32(6)48(60)68-37)69-38-26-53(10,63-17)47(34(8)66-38)71-50-42(59)39(56(14)15)44(33(7)67-50)64-27-35-22-20-19-21-23-35/h19-23,28-34,36-39,41-47,49-50,58-59H,18,24-27H2,1-17H3/t28-,29-,30+,31+,32-,33-,34+,36+,37-,38+,39-,41-,42-,43+,44-,45-,46-,47+,49+,50+,52+,53-,54-/m1/s1
Standard InChI Key: CEALDXCWQZWSRX-HNDACOOESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1037.29 | Molecular Weight (Monoisotopic): 1036.6083 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zhu D, Xu Y, Liu Y, Chen X, Zhao Z, Lei P.. (2013) Synthesis of 4″-O-desosaminyl clarithromycin derivatives and their anti-bacterial activities., 23 (23): [PMID:24139585] [10.1016/j.bmcl.2013.09.083] |
Source(1):